Table 1 Clinical characteristics of NPC patients.
Groups | Low expression | High expression | Test of significance |
|---|---|---|---|
(n = 45) | (n = 50) | ||
Gender | |||
 Male | 34 (75.6%) | 40 (80%) |  |
 Female | 11 (24.4%) | 10 (20%) | P = 0.7843 |
Age | |||
 <50 | 25 (55.6%) | 30 (60%) |  |
 ≥50 | 20 (44.4%) | 20 (40%) | P = 0.8181 |
N stage | |||
 N0 | 5 (11.1%) | 4 (8%) |  |
 Nx | 40 (88.9%) | 46 (92%) | P = 0.868 |
Distant Metastasis | |||
 0 | 44 (97.8%) | 41 (82%) |  |
 1 | 1 (2.2%) | 9 (18%) | P = 0.0302* |
Stage | |||
 Early (1–2) | 8 (17.8%) | 5 (10%) |  |
 Advanced (3-4) | 37 (82.2%) | 45 (90%) | P = 0.4223 |
T Stage | |||
 1 | 7 (15.6%) | 0 (0%) |  |
 2 | 6 (13.3%) | 12 (24%) |  |
 3 | 20 (44.4%) | 24 (48%) |  |
 4 | 12 (26.7%) | 14 (28%) | P = 0.0258* |